These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26490978)

  • 1. Maspin mediates the gemcitabine sensitivity of hormone-independent prostate cancer.
    Huang CY; Chang YJ; Luo SD; Uyanga B; Lin FY; Tai CJ; Huang MT
    Tumour Biol; 2016 Mar; 37(3):4075-82. PubMed ID: 26490978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maspin Enhances the Anticancer Activity of Curcumin in Hormone-refractory Prostate Cancer Cells.
    Cheng WL; Huang CY; Tai CJ; Chang YJ; Hung CS
    Anticancer Res; 2018 Feb; 38(2):863-870. PubMed ID: 29374713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting roles of H3K4me3 and H3K9me3 in regulation of apoptosis and gemcitabine resistance in human pancreatic cancer cells.
    Lu C; Yang D; Sabbatini ME; Colby AH; Grinstaff MW; Oberlies NH; Pearce C; Liu K
    BMC Cancer; 2018 Feb; 18(1):149. PubMed ID: 29409480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docetaxel-resistant prostate cancer cells become sensitive to gemcitabine due to the upregulation of ABCB1.
    Seo HK; Lee SJ; Kwon WA; Jeong KC
    Prostate; 2020 May; 80(6):453-462. PubMed ID: 32134535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Aza-2'-deoxycytidine enhances maspin expression and inhibits proliferation, migration, and invasion of the bladder cancer T24 cell line.
    Zhang H; Qi F; Cao Y; Zu X; Chen M; Li Z; Qi L
    Cancer Biother Radiopharm; 2013 May; 28(4):343-50. PubMed ID: 23570371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosis.
    Tahmatzopoulos A; Sheng S; Kyprianou N
    Oncogene; 2005 Aug; 24(34):5375-83. PubMed ID: 16007219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bax mediates the apoptosis-sensitizing effect of maspin.
    Liu J; Yin S; Reddy N; Spencer C; Sheng S
    Cancer Res; 2004 Mar; 64(5):1703-11. PubMed ID: 14996730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing A7-nAChR levels increases the sensitivity of gastric cancer cells to ixabepilone treatment.
    Tu CC; Huang CY; Cheng WL; Hung CS; Chang YJ; Wei PL
    Tumour Biol; 2016 Jul; 37(7):9493-501. PubMed ID: 26790437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cytoprotective role of gemcitabine-induced autophagy associated with apoptosis inhibition in triple-negative MDA-MB-231 breast cancer cells.
    Chen M; He M; Song Y; Chen L; Xiao P; Wan X; Dai F; Shen P
    Int J Mol Med; 2014 Jul; 34(1):276-82. PubMed ID: 24804820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-29c Increases the Chemosensitivity of Pancreatic Cancer Cells by Inhibiting USP22 Mediated Autophagy.
    Huang L; Hu C; Cao H; Wu X; Wang R; Lu H; Li H; Chen H
    Cell Physiol Biochem; 2018; 47(2):747-758. PubMed ID: 29807360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin-mediated therapeutic efficacy of gemcitabine through glucose-regulated protein 78 in hepatocellular carcinoma.
    Hung CS; Lin SF; Liu HH; Kuo LJ; Li LT; Su HY; Liew PL; Lin FY; Wei PL; Liu DZ; Chang YJ
    Ann Surg Oncol; 2012 Aug; 19(8):2744-52. PubMed ID: 22258814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proapoptotic and antiapoptotic proteins of the Bcl-2 family regulate sensitivity of pancreatic cancer cells toward gemcitabine and T-cell-mediated cytotoxicity.
    Bauer C; Hees C; Sterzik A; Bauernfeind F; Mak'Anyengo R; Duewell P; Lehr HA; Noessner E; Wank R; Trauzold A; Endres S; Dauer M; Schnurr M
    J Immunother; 2015 Apr; 38(3):116-26. PubMed ID: 25751501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [NF-κB subunits regulate maspin expression in prostate cancer cells in vitro].
    Ma L; Shen YY; Zhou P; Zhou J; Guo F
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):165-8. PubMed ID: 22780967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines.
    Celli JP; Solban N; Liang A; Pereira SP; Hasan T
    Lasers Surg Med; 2011 Sep; 43(7):565-74. PubMed ID: 22057484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of oncogenic HMGN5 increases the sensitivity of prostate cancer cells to gemcitabine.
    Guo Z; Zhang X; Li X; Xie F; Su B; Zhang M; Zhou L
    Oncol Rep; 2015 Mar; 33(3):1519-25. PubMed ID: 25572120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis.
    Schniewind B; Christgen M; Kurdow R; Haye S; Kremer B; Kalthoff H; Ungefroren H
    Int J Cancer; 2004 Mar; 109(2):182-8. PubMed ID: 14750167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a non-functional p53 affects the sensitivity of cancer cells to gemcitabine.
    Galmarini CM; Clarke ML; Falette N; Puisieux A; Mackey JR; Dumontet C
    Int J Cancer; 2002 Feb; 97(4):439-45. PubMed ID: 11802204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer.
    Tan Y; Li X; Tian Z; Chen S; Zou J; Lian G; Chen S; Huang K; Chen Y
    Biochem Pharmacol; 2021 Jul; 189():114085. PubMed ID: 32522594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of pancreatic cancer cell apoptosis and enhancement of gemcitabine sensitivity by RAP80 siRNA.
    Li Y; Gu WJ; Liu HL
    Dig Dis Sci; 2012 Aug; 57(8):2072-8. PubMed ID: 22573342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BH3 Mimetic ABT-199 Enhances the Sensitivity of Gemcitabine in Pancreatic Cancer in vitro and in vivo.
    Zhou Y; Liu H; Xue R; Tang W; Zhang S
    Dig Dis Sci; 2018 Dec; 63(12):3367-3375. PubMed ID: 30155839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.